• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阐明细乳糖比例对吸入用干粉流变性能和空气动力学行为的影响。

Elucidating the Effect of Fine Lactose Ratio on the Rheological Properties and Aerodynamic Behavior of Dry Powder for Inhalation.

机构信息

School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang, 110016, China.

出版信息

AAPS J. 2021 Apr 15;23(3):55. doi: 10.1208/s12248-021-00582-0.

DOI:10.1208/s12248-021-00582-0
PMID:33856568
Abstract

Dry powder inhaler (DPI) is recognized as the first choice for lung diseases' treatment. However, it lacks a universal way for DPI formulation development. Fine lactose is commonly added in DPIs to improve delivery performance; however, the fine ratio-dependent mechanism is unclear. Therefore, the objective of this study is to explore the influence of fine lactose ratio on DPI powder properties and aerodynamic behavior, and the fine lactose ratio-dependent mechanism involved during powder fluidization and lung deposition. Here salbutamol sulfate was used as a model drug, Lactohale® 206 as coarse carrier, and Lactohale® 300 as fine component; the mixtures were prepared at 1% drug content, with fine content up to 20%. It was shown that with the fine addition, flowability of the mixtures was improved, interaction among particles was increased, and the presence of fines could help to improve DPI's aerosolization performance. When the fines added were less than 3%, the "active site" hypothesis played a leading role. When the added fines were over 3% but less than 10%, fluidization enhancement mechanism was more important. After the added fines reaching 10%, aggregate mechanism started to dominate. However, FPF cannot be further increased once the fines reached 20%. Moreover, the correlations between FPF and dynamic powder parameters were verified in ternary mixtures, and cohesion had a greater impact on FPF than that of flowability. In conclusion, adding lactose fines is an effective way to improve lung deposition of DPI, with the concrete mechanism lactose fine ratio dependent.

摘要

干粉吸入器(DPI)被认为是肺部疾病治疗的首选。然而,它缺乏一种通用的 DPI 制剂开发方法。细乳糖通常添加到 DPIs 中以改善输送性能;然而,精细比例依赖性机制尚不清楚。因此,本研究的目的是探索细乳糖比例对 DPI 粉末性质和空气动力学行为的影响,以及细乳糖比例依赖性机制在粉末流化和肺部沉积过程中的作用。本文以硫酸沙丁胺醇为模型药物,Lactohale®206 为粗载体,Lactohale®300 为细颗粒;混合物以 1%的药物含量和高达 20%的细颗粒含量制备。结果表明,随着细颗粒的加入,混合物的流动性得到改善,颗粒间的相互作用增加,细颗粒的存在有助于提高 DPI 的雾化性能。当添加的细颗粒小于 3%时,“活性点”假说起主导作用。当添加的细颗粒超过 3%但小于 10%时,流化增强机制更为重要。当添加的细颗粒达到 10%后,团聚机制开始起主导作用。然而,一旦细颗粒达到 20%,FPF 就无法进一步提高。此外,在三元混合物中验证了 FPF 与动态粉末参数之间的相关性,并且与流动性相比,内聚性对 FPF 的影响更大。总之,添加乳糖细颗粒是提高 DPI 肺部沉积的有效方法,具体机制取决于乳糖细颗粒的比例。

相似文献

1
Elucidating the Effect of Fine Lactose Ratio on the Rheological Properties and Aerodynamic Behavior of Dry Powder for Inhalation.阐明细乳糖比例对吸入用干粉流变性能和空气动力学行为的影响。
AAPS J. 2021 Apr 15;23(3):55. doi: 10.1208/s12248-021-00582-0.
2
Elucidation of lactose fine size and drug shape on rheological properties and aerodynamic behavior of dry powders for inhalation.阐明乳糖的细微颗粒大小和药物形状对吸入干粉的流变性能和空气动力学行为的影响。
Eur J Pharm Biopharm. 2022 Oct;179:47-57. doi: 10.1016/j.ejpb.2022.08.007. Epub 2022 Aug 25.
3
Synergistic effect of magnesium stearate and fine lactose in improving aerosolization performance of fluticasone propionate in dry powder formulation.硬脂酸镁和细乳糖协同作用改善丙酸氟替卡松干粉制剂的雾化性能。
Int J Pharm. 2024 Oct 25;664:124609. doi: 10.1016/j.ijpharm.2024.124609. Epub 2024 Aug 18.
4
Powder flow analysis: A simple method to indicate the ideal amount of lactose fines in dry powder inhaler formulations.粉末流动分析:一种指示干粉吸入剂配方中乳糖细粉理想量的简单方法。
Int J Pharm. 2018 Jan 15;535(1-2):59-67. doi: 10.1016/j.ijpharm.2017.10.052. Epub 2017 Oct 31.
5
Exploring the influence of drug content on DPI powder properties and potential prediction of pulmonary drug deposition.探讨药物含量对 DPI 粉末性质的影响及肺部药物沉积的潜在预测。
Int J Pharm. 2020 Feb 15;575:119000. doi: 10.1016/j.ijpharm.2019.119000. Epub 2019 Dec 29.
6
Improved aerosolization performance of salbutamol sulfate formulated with lactose crystallized from binary mixtures of ethanol-acetone.用乙醇-丙酮二元混合物结晶得到的乳糖制备硫酸沙丁胺醇,可改善其气溶胶化性能。
J Pharm Sci. 2011 Jul;100(7):2665-84. doi: 10.1002/jps.22483. Epub 2011 Jan 25.
7
An investigation into the effect of fine lactose particles on the fluidization behaviour and aerosolization performance of carrier-based dry powder inhaler formulations.细乳糖颗粒对载体型干粉吸入剂配方的流化行为和气雾化性能影响的研究。
AAPS PharmSciTech. 2014 Aug;15(4):898-909. doi: 10.1208/s12249-014-0119-6. Epub 2014 Apr 23.
8
Exploring the potential influence of drug charge on downstream deposition behaviour of DPI powders.探讨药物电荷对 DPI 粉末下游沉积行为的潜在影响。
Int J Pharm. 2020 Oct 15;588:119798. doi: 10.1016/j.ijpharm.2020.119798. Epub 2020 Aug 21.
9
Carrier-based dry powder inhalation: Impact of carrier modification on capsule filling processability and in vitro aerodynamic performance.基于载体的干粉吸入剂:载体改性对胶囊填充工艺性能和体外空气动力学性能的影响。
Int J Pharm. 2015 Aug 1;491(1-2):231-42. doi: 10.1016/j.ijpharm.2015.06.044. Epub 2015 Jun 29.
10
Elucidation of the effect of added fines on the performance of dry powder inhalation formulations.阐明添加细粉对干粉吸入制剂性能的影响。
Int J Pharm. 2022 Dec 15;629:122359. doi: 10.1016/j.ijpharm.2022.122359. Epub 2022 Nov 1.

引用本文的文献

1
Different Carriers for Use in Dry Powder Inhalers: Characteristics of Their Particles.干粉吸入器中使用的不同载体:其颗粒特性
J Aerosol Med Pulm Drug Deliv. 2024 Dec;37(6):307-327. doi: 10.1089/jamp.2023.0029. Epub 2024 Aug 9.